Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations by Kühtreiber, Willem M., Tran, Lisa, Kim, Taesoo, Dybala, Michael, Nguyen, Brian, Plager, Sara, Huang, Daniel, Janes, Sophie, Defusco, Audrey, Baum, Danielle, Zheng, Hui, Faustman, Denise L.

Get full text

Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated T regs by Torrey, Heather, Butterworth, John, Mera, Toshiyuki, Okubo, Yoshiaki, Wang, Limei, Baum, Danielle, Defusco, Audrey, Plager, Sara, Warden, Sarah, Huang, Daniel, Vanamee, Eva, Foster, Rosemary, Faustman, Denise L.

Get full text

Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs by Torrey, Heather, Butterworth, John, Mera, Toshiyuki, Okubo, Yoshiaki, Wang, Limei, Baum, Danielle, Defusco, Audrey, Plager, Sara, Warden, Sarah, Huang, Daniel, Vanamee, Eva, Foster, Rosemary, Faustman, Denise L

Get full text

Abstract 1790: TNFR2-targeted elimination of Tregs and tumor-residing T cells in advanced cutaneous T cell lymphoma by Faustman, Denise L., Torrey, Heather, Khodadoust, Michael, Defusco, Audrey, Baum, Danielle, Rahbar, Ziba, Kim, Youn H.

Get full text

Abstract 962: Novel targeting of tumor-infiltrating TNFR2 Tregs: removing suppression with microenvironment-specific antibodies by Torrey, Heather, Butterworth, John, Mera, Toshiyuki, Okubo, Yoshiaki, Wang, Limei, Baum, Danielle, Defusco, Audrey, Plager, Sara, Warden, Sarah, Huang, Daniel, Vanamee, Eva, Foster, Rosemary, Faustman, Denise L.

Get full text

Abstract 2136: Inhibiting cancer growth by targeting the TNFR2 oncogene with TNFR2 antagonistic antibodies by Torrey, Heather, Butterworth, John, Mera, Toshiyuki, Okubo, Yoshiaki, Wang, Limei, Baum, Danielle, Defusco, Audrey, Plager, Sara, Warden, Sarah, Huang, Daniel, Vanamee, Eva, Foster, Rosemary, Faustman, Denise L.

Get full text

Abstract B18: Novel treatment of cutaneous T cell lymphoma: Targeting TNFR2, an oncogene and marker of potent Tregs, with anti-TNFR2 antibodies by Torrey, Heather, Defusco, Audrey, Baum, Danielle, Rhabar, Ziba, Khodadoust, Michael, Kim, Youn H., Faustman, Denise L.

Get full text

Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated T sub(regs) by Torrey, Heather, Butterworth, John, Mera, Toshiyuki, Okubo, Yoshiaki, Wang, Limei, Baum, Danielle, Defusco, Audrey, Plager, Sara, Warden, Sarah, Huang, Daniel, Vanamee, Eva, Foster, Rosemary, Faustman, Denise L

Get full text

MON-179 Repeat BCG Vaccination Creates Lasting HbA1c Reductions in Adult Subjects with Longstanding Type 1 Diabetes by Correcting Immune-Metabolic Defects by Faustman, Denise, Kühtreiber, Willem, Tran, Lisa, Dybala, Michael, Plager, Sara, Janes, Sophie, Defusco, Audrey, Zheng, Hui

Get full text

Abstract PD18-01: Adjuvant Trastuzumab Emtansine Versus Paclitaxel plus Trastuzumab for Stage I HER2+ Breast Cancer: 5-year results and correlative analyses from ATEMPT (TBCRC033) by Tarantino, Paolo, Tayob, Nabihah, Dang, Chau T, Yardley, Denise, Isakoff, Steven J., Valero, Vicente, Faggen, Meredith, Mulvey, Therese, Bose, Ron, Weckstein, Douglas, Wolff, Antonio C., Reeder-Hayes, Katherine, Rugo, Hope, Ramaswamy, Bhuvaneswari, Zuckerman, Dan, Hart, Lowell, Gadi, Vijayakrishna K., Constantine, Michael, Cheng, Kit, Garrett, Audrey Merrill, Marcom, Paul K., Albain, Kathy S., DeFusco, Patricia, Tung, Nadine, Ardman, Blair, Nanda, Rita, Jankowitz, Rachel C., Rimawi, Mothaffar, Abramson, Vandana, Pohlmann, Paula R., Van Poznak, Catherine, Forero-Torres, Andres, Liu, Minetta C., Ruddy, Kathryn, Zheng, Yue, Barroso-Sousa, Romualdo, Waks, Adrienne, DeMeo, Michelle K., DiLullo, Molly K., Curigliano, Giuseppe, Burstein, Harold, Partridge, Ann, Winer, Eric, Viale, Giuseppe, Hui, Winnie, Mittendorf, Elizabeth A., Schneider, Bryan P., Prat, Aleix, Krop, Ian, Tolaney, Sara

Get full text